The Use of the Miyazawa-Jernigan Residue Contact Potential in Analyses of Molecular Interaction and Recognition with Complementary Peptides
暂无分享,去创建一个
Pasko Konjevoda | Nikola Stambuk | Zoran Manojlovic | Renata Novak Kujundzic | P. Konjevoda | N. Štambuk | Z. Manojlovic
[1] Ge Morris. Epitope Mapping: B-cell Epitopes , 2007 .
[2] R. Root-Bernstein,et al. Amino acid pairing. , 1982, Journal of theoretical biology.
[3] Takuya Takahashi,et al. Exhaustive Characterization of TCRâÂÂpMHC Binding Energy Estimated by the String Model and Miyazawa-Jernigan Matrix , 2014 .
[4] M. Šikić,et al. PSAIA – Protein Structure and Interaction Analyzer , 2008, BMC Structural Biology.
[5] G. Rose,et al. Hydrophobicity of amino acid residues in globular proteins. , 1985, Science.
[6] Pasko Konjevoda,et al. Molecular Recognition Theory of the complementary (antisense) peptide interactions , 2005, Theory in Biosciences.
[7] A New Rule-Based System for the Construction and Structural Characterization of Artificial Proteins , 2013 .
[8] P. Kastritis,et al. On the binding affinity of macromolecular interactions: daring to ask why proteins interact , 2013, Journal of The Royal Society Interface.
[9] P. Ponnuswamy,et al. Hydrophobic character of amino acid residues in globular proteins , 1978, Nature.
[10] R. Jernigan,et al. Estimation of effective interresidue contact energies from protein crystal structures: quasi-chemical approximation , 1985 .
[11] R. Root-Bernstein. Peptide self‐aggregation and peptide complementarity as bases for the evolution of peptide receptors: a review , 2005, Journal of molecular recognition : JMR.
[12] S. Sinha,et al. Magnetic bead enzyme-linked immunosorbent assay (ELISA) detects antigen-specific binding by phage-displayed scFv antibodies that are not detected with conventional ELISA. , 1997, Analytical biochemistry.
[13] P. Tongaonkar,et al. A semi‐empirical method for prediction of antigenic determinants on protein antigens , 1990, FEBS letters.
[14] R. Jernigan,et al. Self‐consistent estimation of inter‐residue protein contact energies based on an equilibrium mixture approximation of residues , 1999, Proteins.
[15] Andrew D. Miller. Sense–antisense (complementary) peptide interactions and the proteomic code; potential opportunities in biology and pharmaceutical science , 2015, Expert opinion on biological therapy.
[16] Nikola Štambuk. On the genetic origin of complementary protein coding , 1998 .
[17] S. White,et al. Membrane protein folding and stability: physical principles. , 1999, Annual review of biophysics and biomolecular structure.
[18] K. Bost,et al. Binding of peptides that are specified by complementary RNAs. , 1986, The Biochemical journal.
[19] Wilhelm Schänzer,et al. Annual banned-substance review: analytical approaches in human sports drug testing. , 2010, Drug testing and analysis.
[20] J. Biro. Theoretical Biology and Medical Modelling Open Access the Proteomic Code: a Molecular Recognition Code for Proteins , 2022 .
[21] J. Blalock,et al. Genetic origins of protein shape and interaction rules , 1995, Nature Medicine.
[22] R. Hodges,et al. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. , 1986, Biochemistry.
[23] C. DeLisi,et al. Hydrophobicity scales and computational techniques for detecting amphipathic structures in proteins. , 1987, Journal of molecular biology.
[24] Kaustubh D. Dhole,et al. SPRINGS: Prediction of Protein- Protein Interaction Sites Using Artificial Neural Networks , 2014 .
[25] R. Doolittle,et al. A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.
[26] Andrzej Kloczkowski,et al. Inferring ideal amino acid interaction forms from statistical protein contact potentials , 2005, Proteins.
[27] R. Wolfenden,et al. Water, protein folding, and the genetic code. , 1979, Science.
[28] Sumudu P. Leelananda,et al. Statistical Contact Potentials in Protein Coarse-Grained Modeling: From Pair to Multi-body Potentials , 2011 .
[29] R. Grantham. Amino Acid Difference Formula to Help Explain Protein Evolution , 1974, Science.
[30] R. Root-Bernstein. How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy. , 2015, Anti-cancer agents in medicinal chemistry.
[31] P. Wardęga,et al. A Simple Three-Step Method for Design and Affinity Testing of New Antisense Peptides: An Example of Erythropoietin , 2014, International journal of molecular sciences.
[32] A. Fucic,et al. Hepatoprotective Effects of Met-enkephalin on Acetaminophen-Induced Liver Lesions in Male CBA Mice , 2014, Molecules.
[33] M. Thevis,et al. Annual banned-substance review: analytical approaches in human sports drug testing. , 2010, Drug testing and analysis.
[34] Kuo-Chen Chou,et al. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS , 2003, Biochemical and Biophysical Research Communications.
[35] D. Holmes,et al. Role of complementary proteins in autoimmunity: an old idea re-emerges with new twists. , 2005, Trends in immunology.
[36] P. Konjevoda,et al. Interaction of α-Melanocortin and Its Pentapeptide Antisense LVKAT: Effects on Hepatoprotection in Male CBA Mice , 2011, Molecules.